AZ BIOTECH CONSULTING

Waterloo ·KBO/BCE: BE 0837.974.288

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	19-05-2026	73 d early	2026-00115533
31-12-2024	31-07-2025	16-05-2025	76 d early	2025-00095593
31-12-2023	31-07-2024	21-08-2024	21 d late	2024-00357198
31-12-2022	31-07-2023	30-05-2023	62 d early	2023-00098464
31-12-2021	31-07-2022	12-07-2022	19 d early	2022-20174782
31-12-2020	31-07-2021	30-06-2021	31 d early	2021-30200465
31-12-2019	31-07-2020	30-06-2020	31 d early	2020-23600521
31-12-2018	31-07-2019	25-06-2019	36 d early	2019-22100399
31-12-2017	31-07-2018	10-09-2018	41 d late	2018-62600287
31-12-2016	31-07-2017	22-06-2017	39 d early	2017-20200545

Metric	This company	Sector median	Position in the sector
Solvency	65.0%	55.5%	better than 58% of 4723 sector peers
Net result	€18k	€38k	better than 32% of 4722 sector peers
Equity	€73k	€64k	better than 54% of 4723 sector peers
Gross operating margin	€31k	€61k	better than 30% of 4715 sector peers
Total assets	€112k	€146k	better than 39% of 4723 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€112k
Fixed assets	21/28	€17k
Tangible fixed assets	22/27	€17k
Current assets	29/58	€95k
Amounts receivable within one year	40/41	€23k
Investments	50/53	€51k
Cash & bank	54/58	€9k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€112k
Equity	10/15	€73k
Reserves	13	€72k
Accumulated profits (losses)	14	€571
Amounts payable	17/49	€39k
Amounts payable within one year	42/48	€39k
Trade debts payable within one year	44	€3k
Income statement
Gross operating margin	9900	€31k
Operating result	9901	€27k
Financial income	75	€481
Financial charges	65	€922
Result before taxes	9903	€27k
Income taxes	67/77	€9k
Net result for the period	9904	€18k
Result to be appropriated	9905	€18k

Summary

Legal nameFR	AZ BIOTECH CONSULTING
AbbreviationFR	AZBC